Location History:
- Sete, FR (2017)
- Sète, FR (2014 - 2022)
Company Filing History:
10 out of 5,081 
9 out of 1,743 
7 out of 290 
Years Active: 2014-2022
Title: The Innovative Contributions of Dominique Joubert
Introduction
Dominique Joubert is a prominent inventor based in Sète, France. He has made significant contributions to the field of medical research, particularly in the development of monoclonal antibodies for cancer treatment. With a total of 11 patents to his name, Joubert's work has the potential to impact the lives of many patients suffering from colorectal and liver cancers.
Latest Patents
Joubert's latest patents include groundbreaking work on monoclonal antibodies to progastrin and their uses. This disclosure focuses on progastrin monoclonal antibodies, their fragments, and the compositions that include them. The methods outlined in his patents aim to treat colorectal cancer using these antibodies, as well as to diagnose the disease and monitor the efficacy of anti-cancer therapies. Additionally, he has developed methods and compositions for liver cancer therapy, which involve treating the disease and preventing its recurrence with anti-progastrin antibodies.
Career Highlights
Throughout his career, Joubert has worked with esteemed institutions such as the Centre National de la Recherche Scientifique and the Institut National de la Santé et de la Recherche Médicale. His research has been pivotal in advancing the understanding and treatment of cancer, showcasing his dedication to improving patient outcomes.
Collaborations
Joubert has collaborated with notable individuals, including Frédéric Hollande and Julie Pannequin. These partnerships have further enriched his research and contributed to the development of innovative medical solutions.
Conclusion
Dominique Joubert's contributions to the field of medical research through his patents and collaborations highlight his commitment to advancing cancer treatment. His work continues to inspire future innovations in the medical community.